What’s next for rare myelomas?
The use of venetoclax (ABT-199) in the treatment of CLL
Myeloproliferative neoplasms and pregnancy
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel
Tolerability of monoclonal antibodies in multiple myeloma